Works (2)

Updated: April 5th, 2024 08:35

2015 journal article

CONTRAST-ENHANCED ULTRASOUND IMAGING AND IN VIVO CIRCULATORY KINETICS WITH LOW-BOILING-POINT NANOSCALE PHASE-CHANGE PERFLUOROCARBON AGENTS

ULTRASOUND IN MEDICINE AND BIOLOGY, 41(3), 814–831.

author keywords: Acoustic droplet vaporization; Perfluoropropane; Perfluorobutane; Microbubble; Ultrasound; Contrast agent; Phase change
MeSH headings : Animals; Contrast Media / chemistry; Contrast Media / pharmacokinetics; Fluorocarbons / chemistry; Fluorocarbons / pharmacokinetics; Kidney / blood supply; Kidney / diagnostic imaging; Kinetics; Microbubbles; Phase Transition; Rats; Rats, Inbred F344; Transducers; Ultrasonography / methods
TL;DR: Low-boiling-point nanoscale PCCAs evaluated in vivo can produce contrast enhancement similar to that of microbubbles and can be designed to circulate for as much as 3.3 times longer than microbubble. (via Semantic Scholar)
Source: Web Of Science
Added: August 6, 2018

2014 article

In Vivo Quantification of Image Enhancement and Circulation Kinetics for Phase Change Perfluorocarbon Agents Using Custom Pulse Sequences

2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), pp. 417–420.

By: P. Sheeran n, J. Rojas n, C. Puett n, J. Hjelmquist n, C. Arena n & P. Dayton n

TL;DR: This study develops a custom pulse sequence to vaporize and image droplets using the Verasonics research platform, and demonstrates a novel concept in contrast-enhanced ultrasound: capture of droplet-generated contrast wash-out in the target organ. (via Semantic Scholar)
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.